The initiation of coverage by Morgan Stanley with an Equal-Weight rating suggests a neutral outlook for Axon Enterprise. The price target of $230 indicates the analyst's expectation of the stock's future price, which can influence investor sentiment and potentially impact the stock's price in the short term.